GOTHENBURG, Sweden, April 23, 2026 /PRNewswire/ --

First quarter 

• Sales of SEK 807 (842) million, an increase of 5% in local currencies and 4% decrease in SEK.  
• Sales per region, in local currencies, were -1% in EMEA, +11% in Americas and +7% in APAC.  
• Sales per product group, in local currencies were +9% in Consumables, +11% in Technologies and -1% in Genetics.  
• Gross margin increase to 59.9% (57.4).  
• Earnings before depreciation and amortisation (EBITDA) amounted to SEK 251 (257) million, resulting in an EBITDA margin of 31.1% (30.6).  
• Net income amounted to SEK 101 (100) million, resulting in earnings per share of SEK 0.74 (0.74).  
• Operating cash flow amounted to SEK 172 (69) million. 

Gothenburg, April 23, 2026 
VITROLIFE AB (publ) 
Bronwyn Brophy O´Connor, CEO 

This disclosure contains information that Vitrolife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 23-04-2026 08:00 CET.

Contact: 
Pär Ihrskog, CFO
e-mail: investors@vitrolife.com  
phone: +46 (0) 31 721 80 00 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/interim-report-q1--2026--strong-growth-in-consumables-and-technologies,c4338311

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/vitrolife-ab-publ---interim-report-q1-2026-strong-growth-in-consumables-and-technologies-302751418.html

SOURCE Vitrolife AB (publ)